Article
Baseline Lymphopenia: A Predictor Of Poor Outcomes In HER2 positive Metastatic Breast…
Drug Design, Development and Therapy · 2019 · Che YQ, Zhang Y, Wang D, Liu HY, Shen D, Luo Y
Key facts
| Title | Baseline Lymphopenia: A Predictor Of Poor Outcomes In HER2 positive Metastatic Breast Cancer Treated With Trastuzumab |
|---|---|
| First author | Che YQ, Zhang Y, Wang D, Liu HY, Shen D, Luo Y |
| Journal | Drug Design, Development and Therapy |
| Published | Oct 29, 2019 |
| DOI | 10.2147/DDDT.S212610 |
| Devices mentioned | 212610 |
| Product codes mentioned | LXH |
At a glance
- 1–9 FDA submissions mentioned
- 1–9 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1